Axcelis Technologies, Inc. $ACLS Stake Lifted by Reinhart Partners LLC.

Reinhart Partners LLC. grew its stake in Axcelis Technologies, Inc. (NASDAQ:ACLS) by 14.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,060,636 shares of the semiconductor company’s stock after purchasing an additional 131,976 shares during the period. Axcelis Technologies comprises approximately 3.4% of Reinhart Partners LLC.’s investment portfolio, making the stock its 10th largest holding. Reinhart Partners LLC. owned 3.43% of Axcelis Technologies worth $139,134,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. GAMMA Investing LLC boosted its holdings in Axcelis Technologies by 5.7% during the third quarter. GAMMA Investing LLC now owns 3,051 shares of the semiconductor company’s stock worth $400,000 after buying an additional 164 shares in the last quarter. Central Pacific Bank Trust Division raised its position in shares of Axcelis Technologies by 47.9% in the third quarter. Central Pacific Bank Trust Division now owns 5,567 shares of the semiconductor company’s stock worth $730,000 after acquiring an additional 1,802 shares during the period. MassMutual Private Wealth & Trust FSB raised its position in shares of Axcelis Technologies by 25.9% in the third quarter. MassMutual Private Wealth & Trust FSB now owns 598 shares of the semiconductor company’s stock worth $78,000 after acquiring an additional 123 shares during the period. Cim Investment Management Inc. purchased a new stake in shares of Axcelis Technologies during the 2nd quarter worth about $301,000. Finally, QRG Capital Management Inc. boosted its stake in shares of Axcelis Technologies by 6.9% during the 2nd quarter. QRG Capital Management Inc. now owns 10,254 shares of the semiconductor company’s stock worth $1,942,000 after acquiring an additional 658 shares in the last quarter. Institutional investors and hedge funds own 89.98% of the company’s stock.

Axcelis Technologies Stock Performance

ACLS opened at $134.71 on Friday. The firm’s fifty day simple moving average is $125.08 and its two-hundred day simple moving average is $135.93. Axcelis Technologies, Inc. has a 52-week low of $73.60 and a 52-week high of $193.78. The company has a market cap of $4.16 billion, a price-to-earnings ratio of 45.20, a PEG ratio of 4.08 and a beta of 1.86. The company has a quick ratio of 3.21, a current ratio of 4.90 and a debt-to-equity ratio of 0.04.

Axcelis Technologies (NASDAQ:ACLS) last released its earnings results on Thursday, August 6th. The semiconductor company reported $1.06 EPS for the quarter, topping analysts’ consensus estimates of $0.89 by $0.17. Axcelis Technologies had a net margin of 10.71% and a return on equity of 11.69%. The business had revenue of $215.18 million during the quarter, compared to analysts’ expectations of $205.03 million. During the same quarter in the previous year, the company earned $1.13 earnings per share. The company’s quarterly revenue was up 10.6% on a year-over-year basis. Axcelis Technologies has set its Q3 2026 guidance at 1.110-1.110 EPS. Equities analysts anticipate that Axcelis Technologies, Inc. will post 3.39 earnings per share for the current fiscal year.

Analysts Set New Price Targets

ACLS has been the topic of a number of analyst reports. Craig Hallum cut Axcelis Technologies from a “buy” rating to a “hold” rating and set a $140.00 target price on the stock. in a research report on Friday, August 7th. Bank of America increased their price target on Axcelis Technologies from $130.00 to $156.00 and gave the stock an “underperform” rating in a research report on Tuesday, June 23rd. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Axcelis Technologies in a report on Friday, August 7th. One analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $148.67.

About Axcelis Technologies

Axcelis Technologies, Inc (NASDAQ: ACLS) develops and manufactures equipment used in semiconductor fabrication. The company’s primary business is ion implantation, a process that modifies the electrical properties of silicon and other semiconductor materials by introducing controlled amounts of dopants. Its systems are used by chip manufacturers to produce a range of semiconductor devices.

Axcelis offers the Purion family of ion implantation systems, including platforms designed for high-current, medium-current and high-energy applications.